Novo Nordisk said the shortage of lower strengths of its diabetes drug Ozempic has deteriorated, with intermittent shortages ...

Intermittent shortages of diabetes drug Ozempic in the European Union that are expected to continue into the final quarter of ...

We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. In this article, we are ...

Kepler Capital analyst David Evans maintained a Hold rating on Novo Nordisk (0QIU – Research Report) on September 6 and set a price ...

Sun Pharma of India and Mylan Pharmaceuticals of West Virginia seek FDA approval of generic versions of the popular ...

Out of all of the special options we uncovered, 7 are puts, for a total amount of $295,009, and 5 are calls, for a total ...

Novo Nordisk's launch of weight-loss and diabetes drugs Wegovy and Ozempic in India hinges on resolving supply issues. The ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Novo Nordisk ( NVO) has said in a note published by the European Medicines Agency that the supply shortage of its diabetes ...

Novo Nordisk is working to resolve supply issues that are affecting the launch of its weight-loss and diabetes medications, ...

A pair of late-stage trials found that Eli Lilly’s experimental once-weekly insulin can lower blood sugar as effectively as ...

The European market is facing shortages of Novo Nordisk's (NYSE: NVO) injectable glucagon-like peptide-1 receptor agonist ...